CRBP logoCRBP
Corbus Pharmaceuticals Holdings Inc

21,519
Loading...
Loading...
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28

Frequently Asked Questions

What is Market Cap of Corbus Pharmaceuticals Holdings Inc?
What is the 52-week high for Corbus Pharmaceuticals Holdings Inc?
What is the 52-week low for Corbus Pharmaceuticals Holdings Inc?
What is Corbus Pharmaceuticals Holdings Inc stock price today?
What was Corbus Pharmaceuticals Holdings Inc stock price yesterday?
What is the PE ratio of Corbus Pharmaceuticals Holdings Inc?
What is the Price-to-Book ratio of Corbus Pharmaceuticals Holdings Inc?
What is the 50-day moving average of Corbus Pharmaceuticals Holdings Inc?
How many employess does Corbus Pharmaceuticals Holdings Inc has?

Latest CRBP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.